0001171843-13-004524.txt : 20131108 0001171843-13-004524.hdr.sgml : 20131108 20131108123028 ACCESSION NUMBER: 0001171843-13-004524 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20131108 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20131108 DATE AS OF CHANGE: 20131108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED GUARDIAN INC CENTRAL INDEX KEY: 0000101295 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 111719724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10526 FILM NUMBER: 131203502 BUSINESS ADDRESS: STREET 1: 230 MARCUS BLVD CITY: HAUPPAUGE STATE: NY ZIP: 11788 BUSINESS PHONE: 631-273-0900 MAIL ADDRESS: STREET 1: P.O. BOX 18050 STREET 2: 230 MARCUS BLVD. CITY: HAUPPAUGE STATE: NY ZIP: 11788 FORMER COMPANY: FORMER CONFORMED NAME: UNITED INTERNATIONAL RESEARCH INC DATE OF NAME CHANGE: 19820422 8-K 1 document.htm FORM 8-K FILING DOCUMENT Form 8-K Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 8, 2013


United-Guardian, Inc.
(Exact name of registrant as specified in its charter)


Delaware

001-10526

11-1719724
(State or other jurisdiction
of incorporation)
(Commission File Number) (IRS Employer
Identification No.)


230 Marcus Boulevard, Hauppauge, New York 11788
(Address of principal executive offices)


Registrant's telephone number, including area code: (631) 273-0900


Not Applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

  [   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  [   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  [   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02. Results of Operations and Financial Condition.

On November 8, 2013 the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

    Exhibit 99.1.       Press release dated November 8, 2013


SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

United-Guardian, Inc.

Date: November 8, 2013 By:   /s/   KEN GLOBUS
Ken Globus
President




  Exhibit Index
  99.1 Press release dated November 8, 2013






EX-99 2 newsrelease.htm PRESS RELEASE United-Guardian Reports Strong Third Quarter Earnings

EXHIBIT 99.1

United-Guardian Reports Strong Third Quarter Earnings

HAUPPAUGE, N.Y., Nov. 8, 2013 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (Nasdaq:UG) announced today that net income for the third quarter of 2013 increased by 14% over the third quarter of last year, with earnings per share increasing from $0.24 to $0.28. Net income for the nine-month period ended September 30, 2013 increased from $3,537,875 to $4,183,980 when compared with the same period in 2012. This represents an increase of 18% over last year and a new nine-month record for the company. Earnings per share for the nine-month period also reached a record high of $0.91, compared with $0.77 for the first nine months of 2012.

Ken Globus, United-Guardian's President, stated, "We are very pleased to have attained this record level of earnings despite the fact that there were no sales of Renacidin® Irrigation, our largest pharmaceutical product, for the first nine months of 2013. This was due to manufacturing issues experienced by our Renacidin supplier. I am happy to report that those issues have now be rectified, and we have just received our first Renacidin shipment and have begun resupplying our distributors. We also benefited from increased sales of our personal care products, which made up for most of the shortfall that resulted from the loss of Renacidin sales. With the resumption of Renacidin sales, as well as continued strong demand for our personal care products, we are optimistic that 2013 will be a record year for profits."

United-Guardian is a manufacturer of cosmetic ingredients, personal and health care products, pharmaceuticals, and specialty industrial products.  

NOTE:   This press release contains both historical and "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements about the company's expectations or beliefs concerning future events, such as financial performance, business prospects, and similar matters, are being made in reliance upon the "safe harbor" provisions of that Act. Such statements are subject to a variety of factors that could cause our actual results or performance to differ materially from the anticipated results or performance expressed or implied by such forward-looking statements. For further information about the risks and uncertainties that may affect the company's business please refer to the company's reports and filings with the Securities and Exchange Commission.

 
RESULTS FOR THE THREE AND NINE MONTHS ENDED
SEPTEMBER 30, 2013 and SEPTEMBER 30, 2012
(UNAUDITED)
 
  THREE MONTHS ENDED
SEPTEMBER 30,
 NINE MONTHS ENDED
 SEPTEMBER 30,
   2013  2012 2013 2012
         
Net sales $ 3,404,227 $ 3,527,387 $ 10,984,959 $ 11,151,179
         
Costs and expenses:        
Cost of sales 1,211,678 1,334,491 3,986,129 4,339,450
Operating expenses  654,027  598,100 1,851,486 1,749,217
Total costs and expenses 1,865,705 1,932,591 5,837,615 6,088,667
         
Income from operations 1,538,522 1,594,796 5,147,344 5,062,512
         
Other income:        
Investment income  47,739 51,065  166,846 162,413
Gain on sale of assets  -- --  --  2,750
Income from damage settlement  292,830  --  878,490  --
Total other income   340,569  51,065  1,045,336  165,163
         
Income before income taxes 1,879,091 1,645,861 6,192,680 5,227,675
         
Provision for income taxes 602,300  529,700  2,008,700  1,689,800
         
Net Income $ 1,276,791 $ 1,116,161  $ 4,183,980 $ 3,537,875
         
Earnings per common share (Basic and Diluted) $ 0.28 $ 0.24 $ 0.91 $ 0.77
         
Weighted average shares – basic and diluted 4,596,439 4,596,439 4,596,439 4,596,439

Additional financial information can be found at the company's web site at www.u-g.com.

CONTACT: Robert S. Rubinger
         Public Relations
         (631) 273-0900